Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PMN | US
-0.46
-3.74%
Healthcare
Biotechnology
30/06/2024
16/04/2026
11.84
12.01
12.63
11.22
ProMIS Neurosciences Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310 a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267 a TDP-43; and PMN442 a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences Inc. in July 2015. ProMIS Neurosciences Inc. was incorporated in 2004 and is headquartered in Toronto Canada.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
120.7%1 month
106.3%3 months
120.5%6 months
107.0%-
-
300.04
-
-
-1.74
3.87K
-
-11.15M
353.84M
353.84M
-
-
-
-
-1.10K
1.98
0.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
3.23
Range1M
9.54
Range3M
19.42
Rel. volume
2.27
Price X volume
1.05M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CytomX Therapeutics Inc | CTMX | Biotechnology | 4.89 | 375.52M | 7.24% | 7.73 | -37.61% |
| Cerus Corporation | CERS | Biotechnology | 2 | 370.59M | -0.99% | n/a | 199.34% |
| Xilio Therapeutics Inc. Common Stock | XLO | Biotechnology | 8.35 | 367.00M | -0.60% | n/a | 25.98% |
| Absci Corporation Common Stock | ABSI | Biotechnology | 3.23 | 366.79M | 1.89% | n/a | 6.02% |
| Kazia Therapeutics Limited | KZIA | Biotechnology | 10.92 | 363.47M | 9.20% | n/a | 6.82% |
| Zentalis Pharmaceuticals LLC | ZNTL | Biotechnology | 5.02 | 356.96M | -6.34% | n/a | 11.51% |
| Greenwich LifeSciences Inc | GLSI | Biotechnology | 27.1 | 356.22M | 4.59% | n/a | 0.00% |
| Silence Therapeutics plc | SLN | Biotechnology | 7.6 | 355.66M | 4.40% | n/a | 0.16% |
| Puma Biotechnology Inc | PBYI | Biotechnology | 7.24 | 355.10M | -3.21% | 15.16 | 203.23% |
| Rocket Pharmaceuticals Inc | RCKT | Biotechnology | 3.9 | 354.81M | 0.52% | n/a | 6.71% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 22.01 | 365.53M | 0.23% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.27 | 328.09M | 5.98% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.24 | 310.38M | 1.25% | n/a | 174.23% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.63 | 264.90M | 0.39% | 13.23 | 0.00% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.87 | 258.15M | 0.00% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 17.89 | 199.61M | 1.02% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.74 | 156.39M | 0.72% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.99 | 100.48M | 0.63% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.12 | 99.69M | 0.49% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.93 | 74.70M | 1.14% | 14.48 | 7.10% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.74 | - | Cheaper |
| Ent. to Revenue | 3,868.08 | - | Par |
| PE Ratio | - | 41.03 | - |
| Price to Book | 300.04 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 120.52 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 353.84M | - | Emerging |